China News Network Lanzhou, March 14th (Reporter Xu Xue) The 2020 work conference disclosed in Lanzhou High-tech Zone on the 13th is committed to focusing on the first industry of biomedicine, implementing a biomedical innovation enterprise cultivation action plan, integrating element resources, and nurturing First aid. In terms of measures, efforts will be made to introduce "head enterprises" and "seed enterprises" to support the "half the sky" of Gansu's top ten ecological industry biomedicine.
Gansu is one of the main producing areas of Chinese medicinal materials. Biomedical R & D and production has a good foundation in the country. Especially, the provincial capital Lanzhou relies on rich medical resources and concentrated scientific research capabilities, and has formed biopharmaceuticals, modern Chinese medicine, biomedical engineering and animals. The biomedical industry system focusing on drug use has gathered 11 colleges and universities and 22 scientific research institutes that are closely related to the biomedical industry, and more than 6,000 technical personnel in related fields.
The picture shows the raw material separation operation performed by the staff of Lanzhou Rongying Biotechnology Co., Ltd. Photo by Zhang Zhendong
Located in the northwest of Gansu, research and judge the advantages of occupying geographical advantages, and proposed the "top ten ecological industries" to be cultivated include "traditional Chinese medicine and traditional Chinese medicine", and the research and development and production of biomedicine is a key to this industry.
"Taking modern Chinese medicine and biotechnology as the focus, focusing on biopharmaceuticals, authentic medicinal materials development and other fields, internal and external linkages will be established to build a biopharmaceutical industry cluster," said Wang Fangtai, member of the Standing Committee of the Lanzhou Municipal Party Committee, Secretary of the Municipal Party Committee, and Secretary of the Party Committee of the High-tech Zone. Said that the district will focus on cultivating and strengthening backbone enterprises such as Zhongnong Witt, constructing animal husbandry production bases for China Animal Husbandry, advancing the construction progress of heavy ion, Lanzhou Bio-Industrial Park, Lanzhou Hi-tech Modern Medicine Logistics Park and other projects, and supporting Guangzhou Pharmaceutical Group Wanglao Jilan Grand Health The Zhongsheng Medical Beauty Industrial Park project has accelerated the construction, promoted the construction of cell bank, gene bank and peptide bank, and planned Lanzhou peptide valley.
The head of Zhongnong Witt said in an interview with the media that at the beginning, it was like a “small workshop”. In more than 10 years, it has two internationally advanced GMP workshops for foot-and-mouth disease vaccine. In recent years, Lanzhou City has increasingly supported science and technology enterprises, and they have received a lot of support.
According to public information disclosure, the Zhongnong Weite Biomedical Base Project with a total investment of about 1 billion yuan is accelerating the construction of the eastern science and technology city of Lanzhou High-tech Zone.
The working conference proposed that in terms of the construction of major projects, the Lanzhou High-tech Zone focused on the three issues of "people", "money" and "land" that affected the project's implementation, deepened the "three assistance and docking mechanisms", and fully implemented the "nanny-style" "Service, to implement the early stage of the project, to standardize project management, and to urge the established project to start early and build early.
Sun Yu, director of the Management Committee of Lanzhou High-tech Zone, said at a working conference that this year, 700 million yuan in Lanzhou's self-made zone investment guidance fund and bio-medical industry development funds are planned to be established, which will cultivate scientific and technological enterprises, industrialize major R & D projects, Support the construction of public technology service platforms.
"For companies that have good growth potential, high growth potential, and high profits in the industry, we must give priority to fostering them, help them become stronger and better as soon as possible, counsel listings, and promote the breakthrough of the" unicorn "companies in the biomedical field. Cultivate a number of regionally competitive 'gazelle' enterprises, new champion enterprises, specialised special new 'little giant' enterprises, and 'single champion' enterprises in the niche sector. "Wang Fangtai also proposed standards for supporting enterprises here. And development goals.
At the end of 2019, Lanzhou High-tech Zone hosted a science and technology innovation conference in an independent innovation demonstration zone, and rewarded outstanding companies and teams. 110 companies including Gansu Longshenrong Pharmaceutical Co., Ltd., and 6 teams including Lanzhou Peptide Biomedical Technology Co., Ltd.'s innovation and entrepreneurial talent team received awards, totaling 138 policy items and cashing funds of 34.77 million yuan. (Finish)